ASXL1 and chronic myelomonocytic leukemia: ASXL1 is mutated (deleted or truncated) at high frequencies in all forms of myeloid malignancy21,22; it is associated with poor prognosis in patients with chronic myelomonocytic leukemia (CMML), MDS, myelofibrosis, and AML23,24.